Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posttransplantation: emerging and future therapies.

R P Perrillo1, M Kruger, T Sievers

  • 1Ochsner Clinics, New Orleans, Louisiana, USA.

Seminars in Liver Disease
|July 15, 2000
PubMed
Summary

Preventing hepatitis B virus (HBV) recurrence after liver transplant is crucial. New strategies aim to reduce HBV DNA replication before surgery, improving transplant success and patient survival by minimizing reinfection risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurements of Chemical Potentials in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

[Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment].

Die Ophthalmologie·2024
Same author

Observation of Medium-Induced Yield Enhancement and Acoplanarity Broadening of Low-p_{T} Jets from Measurements in pp and Central Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Response to Doctors for Life.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Photoproduction of K^{+}K^{-} Pairs in Ultraperipheral Collisions.

Physical review letters·2024
Same author

In silico Mechanics of Stem Cells Intramyocardially Transplanted with a Biomaterial Injectate for Treatment of Myocardial Infarction.

Cardiovascular engineering and technology·2024

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Immunology

Background:

  • Hepatitis B virus (HBV) reinfection is a major challenge after liver transplantation, often leading to graft loss and reduced survival.
  • Current standard of care involves lifelong hepatitis B immune globulin (HBIG) to prevent reinfection.

Purpose of the Study:

  • To explore novel strategies for decreasing HBV DNA replication prior to liver transplantation.
  • To enhance transplant success rates by mitigating the risk of post-transplant HBV recurrence.

Main Methods:

  • Review of current and emerging management strategies for HBV patients undergoing liver transplantation.
  • Evaluation of nucleoside analogues (e.g., ganciclovir, famciclovir, lamivudine) and HBIG in preventing viral recurrence.
  • Assessment of combination therapy to minimize the risk of antiviral resistance and viral mutation.

Related Experiment Videos

Main Results:

  • Nucleoside analogues show varying efficacy in preventing HBV recurrence, with potential for resistance development.
  • Combination therapy may reduce the incidence of viral mutation.
  • Pre-transplant reduction of HBV DNA replication is a promising approach to improve outcomes.

Conclusions:

  • Newer management strategies, including pre-transplant viral load reduction and combination therapies, are vital for improving liver transplant outcomes in HBV patients.
  • Ongoing research is essential to develop more effective methods for preventing and treating HBV recurrence post-transplantation.